Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups  by Choi, Seok-Ki et al.
Monomeric inhibitors of influenza neuraminidase enhance 
the hemagglutination inhibition activities of 
polyacrylamides presenting multiple C-sialoside groups 
Seok-Ki Choi, Mathai Mammen and George M Whitesides* 
Department of Chemistry, Harvard University, 12 Oxford Street, Cambridge, MA 02138, USA 
Background: Influenza viruses use hemagglutinin (HA) 
arrays to bind to sialic acid moieties on the surface of cells; 
crosslinking of erythrocytes by this mechanism leads to 
hemagglutination. A number of synthetic polymers con- 
taining multiple sialic acid (Neu5Ac) groups as side chains 
are potent inhibitors of this process. Inhibition may be due 
to two mechanisms: polyvalent binding of the inhibitor’s 
multiple Neu5Ac side chains to multiple HA sites on the 
viral surface, or steric stabilization of the viral particle by a 
layer of the adsorbed, water-swollen polymer, which pre- 
vents adhesion to the erythrocyte. The balance between 
these two effects is not yet known. 
Results: Polyacrylamides with multiple C-sialosides 
(PA(Neu5Ac)) were 2-20 fold more effective as inhibitors 
of virally mediated hemagglutination when assayed in the 
presence of Neu2en-NHz, a potent monomeric inhibitor 
of influenza neuraminidase (NA). The ability of 
monomeric inhibitors of NA to enhance the inhibition 
of hemagglutination in this assay correlated with the 
affinity of the monomer for NA. 
Conclusions: We propose that inhibitors of NA act by 
competing with the C-sialosides of PA(Neu5Ac) for 
binding to the active sites of the NA. Competitive dis- 
placement of Neu5Ac causes an expansion of the layer of 
polymeric gel adsorbed to the virus, enhancing its 
inhibitory effect. This study provides an example of 
synergy between two ligands directed toward the active 
sites of two different proteins, and reinforces the conclu- 
sion that steric stabilization is important for the activity of 
polyvalent inhibitors. 
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Introduction 
Influenza virus A is the causative agent of a serious disease 
in humans [1,2].The virus initiates infection by attaching 
to multiple sialyl (N-acetylneuraminic acid, Neu5Ac) 
moieties on the surface of mammalian epithelial cells in 
the upper respiratory system, via hemagglutinin (HA) on 
the viral surface (Fig. 1) [3-51. HA exists as a symmetric 
trimer ([HA]J, and extends -135 A from the lipid mem- 
brane of the viral surface. HA is expressed at a density of 
-200-300 [HA], units per virion, comprising -80-90 % 
of all the proteins on the surface. Viral neuraminidase 
WA) 2 another surface glycoprotein, is a hydrolytic 
enzyme that catalyzes cleavage of the o-0-glycosidic 
linkage of Neu5Ac; this bond connects Neu5Ac to a 
variety of aglycons on the surface of the target cell [6,7]. 
NA exists as a tetramer ([NA],), which extends -60 A 
from the surface, and each virion contains -20-40 copies 
of [NA],. Thus, in viva, a-glycosides of Neu5Ac are both 
substrates for NA and ligands for HA.The action of NA 
is curiously opposite to that of HA; the former releases 
the virus from the cellular surface, whereas the latter 
attaches it. The enzymatic action of NA may be impor- 
tant in facilitating the penetration of virus to the target 
cell through the mucous layer, which is rich in a variety 
of NeuSAc-containing mucins, as well as in promoting 
release of newly formed virions from the surface of 
infected cells [7]. 
An important consideration in designing strategies to 
block adhesion of influenza virus to cells is that the virus 
binds to the cell strongly, although individual viral 
surface receptors bind individual cell-surface ligands 
weakly. In5uenza virus attaches to the surface of an ery- 
throcyte using multiple interactions between clusters of 
HA and sialyl residues on the surface of the erythrocyte 
with an apparent KdHA of < 1 O-l2 M [8-lo], while 
bromelain-cleaved HA (HA that has been cleaved from 
the surface of the virus; BHA) binds to a-methyl sialo- 
sides (Neu5Ac-OMe in Fig. lb) more weakly by a factor 
of-lo9 (Kd HA = 2.5 x 10m3 M) [11,12].This large differ- 
ence is due to polyvalent binding of viral receptors to 
cellular ligands. 
To inhibit this polyvalent interaction between the virus 
and cell, we have designed and synthesized a number of 
polyvalent inhibitors [ 131, in particular polymers that 
present multiple Neu5Ac groups on side chains. These 
polyvalent inhibitors are more effective inhibitors of 
hemagglutination than structurally analogous mono- 
valent derivatives by a factor of 104-10’ (per Neu5Ac 
ligand) [8,10,13-161, and are currently the most potent 
of all synthetic or natural inhibitors [ 131. 
There are at least two mechanisms that might, in prin- 
ciple, underlie the remarkable effectiveness of these 
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Fig.1. The biological system and the com- 
pounds used in this study. (a) A schematic 
model showing adsorption of influenza 
virus to a target cell, which is the initial, 
necessary step of viral infection [4]. The 
attachment occurs through interactions 
between viral HA and sialyl moieties on 
the surface of the target cell. (b) Structure 
of Neu5Ac (N-acetylneuraminic acid; 
sialic acid) and analogs. (c) Structures of 
Neu2en (2,3-dehydroneuraminic acid) 
and analogs. These compounds are 
potent inhibitors of influenza NA. 
polymeric species as inhibitors of the adhesion of virus 
to cells. The first mechanism involves high affinity 
resulting from polyvalent binding; the Neu5Ac groups 
on the side chains of the polymer might bind coopera- 
tively to the HA on the surface of virus. Alternatively, 
the polymeric inhibitors may work by steric stabiliza- 
tion of the virus against association with the erythro- 
cyte; parts of the polymer not involved directly in 
binding to HA may make the surface of the virus steri- 
tally inaccessible to the surface of the target cell.These 
two mechanisms might operate independently or addi- 
tively, but yield the same effect - enhanced inhibition 
of hemagglutination. The two mechanisms are almost 
certainly countered, to some extent, by steric interfer- 
ence of binding of the Neu5Ac to HA by the backbone 
of the polymer; a single ligand attached to a polymer 
might bind less tightly to a receptor than the same 
unattached ligand [ 141. 
Here we describe the influence of monomeric 
inhibitors of influenza NA on the ability of polymers 
presenting multiple Neu5Ac groups to inhibit the 
agglutination of erythrocytes by influenza virus. We use 
these data to clarify the modes of action of the poly- 
mers. First, we demonstrate that the effectiveness of 
certain polymers can be enhanced by factors of 2-20 
when assayed in a system that includes Neu2en-NH2 
[171, which is a potent competitive inhibitor of 
NA (K.NA = 50 nM) but a poor ligand for HA 
(KdHA 2’50 mM). The enhancement results from a 
combined use of two classes of inhibitors; the action of 
either inhibitor alone cannot account for the observed 
activities. Second, the inhibition constants of three dif- 
ferent monomeric inhibitors of NA (KiNA) correlated 
with the concentrations of these inhibitors required to 
enhance the hemagglutinin inhibition (HAI) activities 
of the polymers. This correlation suggests strongly that 
the enhancement of inhibition of hemagglutination by 
the polymers is a result of specific binding of 
monomeric inhibitors of NA to the active sites of NA. 
Results and discussion 
Preparation of inhibitors of influenza virus 
We prepared derivatives of polyacrylamide having 
or-C-glycosidic Neu5Ac groups (Neu5Ac-NH,; Fig. 
lb) as side chains.These polymers inhibited the aggluti- 
nation of erythrocytes by influenza virus [ 131. We used 
an a-C-glycosidic linkage rather than an a-O-glyco- 
sidic linkage between the Neu5Ac group and the 
linking side chain to prevent the hydrolytic cleavage of 
a-0-glycosidic Neu5Ac, which is catalyzed by NA (the 
value of the Michaelis constant, K,,,, of Neu5Ac(or2,3)- 
lactose is 0.2 mM for NA from influenza virus) [18]. 
This instability to NA-catalyzed cleavage has been a 
major drawback of polymeric species containing 
a-0-sialoside groups as inhibitors of hemagglutination 
(e.g., the naturally occurring inhibitors of infection by 
influenza virus, such as clu,-macroglobulin, have this 
limitation). The polymers containing an a-C-glycosidic 
linkage are inert to hydrolysis by NA. Neu5Ac groups 
coupled via ol-C-glycosidic linkages are believed to 
bind to HA (and NA) in the same manner as the 
c-w-0-sialoside, based on the crystal structures of the 
complexes of HA and NA with their ligand 
[3,12,19,201, in which the oxygen atom of the 
a-o-linkage does not interact with the active-site 
residues significantly. 
The a-0-sialosides bind weakly to NA. By contrast, 
some 2,3-dehydroneuraminic acids (Neu2en; Fig. 1 c) 
bind tightly to NA [17,21] .The molecular basis of this 
tight interaction is probably the similarity in structure 
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between Neu2en and the transition state for the 
NA-catalyzed hydrolysis of cr-0-sialosides. Neu2en is 
the core of a class of potent inhibitors of influenza NA 
that mimic the hydrolytic transition state, such as 
4-guanidinoNeu2en (Ki NA = 0.2 nM), Neu2en-NH2 
(K-NA = 50 nM), Neu2en-OH (K,NA = 1 PM), and 
N&2en-NJ (believed to be the least potent analog as 
judged from K, for NA from other sources, although 
the value of K, for influenza NA is not available) 
[ 17,20,22,23]. We synthesized these analogs of Neu2en 
using methods developed by von Itzstein et al. [22]. 
The synthesis of polyacrylamides presenting a-c-glyco- 
sidic Neu5Ac groups as side chains [13,16] is summa- 
rized in Figure 2. We first prepared a polymer 
(poly(Ri-acryloyloxysuccinimide), pNAS) that has car- 
boxylic acids preactivated for reaction with amine-con- 
taining nucleophiles by radical-initiated polymerization 
of N-acryloyloxysuccinimide [ 131. We allowed this 
homopolymer to react with x equivalents of Neu5Ac- 
NH, (x = 0.05, 0.2, 0.35, 0.6 or 1.0 molar equivalents 
per mole of activated ester on the polymer); here x 
denotes the mole fraction of Neu5Ac in the polymers 
and is defined as the number of side chains containing 
Neu5Ac divided by the total number of side chains. 
Subsequent reaction with excess ammonia converted 
unreacted N-hydroxysuccinimide esters to primary 
amide groups. These two reactions yielded polyacry- 
lamide with pendant C-sialosides. For most of the poly- 
mers, the experimental value of xNeu5Ac (obtained from 
analysis of both integrations of lH-NMR spectra and 
sulfur/nitrogen ratios following complete oxidative com- 
bustion) was generally about 10 o/o lower than that pre- 
dicted theoretically [13]. For simplicity in nomenclature, 
we refer to these polymeric C-sialosides as PA(Neu5Ac, 
x = 0.05, 0.2, 0.35, 0.6, 1 .O). This synthetic strategy, 
which uses the modification of a preformed, reactive 
homopolymer to make a (formal) copolymer having two 
(or more) types of side chains, enabled us to prepare a 
wide range of polymers having the same polydispersity 
and polytacticity, but with controlled densities of biologic- 
ally-active functional groups along the backbone of the 
polymer [13,24]. 
Fig. 2. Preparation of PA(Neu5Ac), poly- 
acrylamides with side chains containing 
multiple copies of a-C-sialosides 1131. 
The reaction conditions are: i) 2,2’- 
azobis-iso-butyronitrile (AIBN), tetra- 
hydrofuran (THF), 60 “C, ii) x molar 
equivalents of Neu5Ac-NH2 (per mole of 
activated ester on the polymer), triethyl- 
amine (EtaN), N,N-dimethylformamide 
(DMF), room temperature, iii) excess 
ammonia, iv) dialysis against distilled 
water. By varying the number of equiva- 
lents of Neu5Ac-NH2 (~1, five polymers, 
PA(Neu5Ac, x = 0.05, 0.2, 0.35, 0.6, 
1 .O), were prepared, where x denotes the 
mole fraction of Neu5Ac in the polymers 
and is defined as the number of side 
chains containing Neu5Ac divided by 
the total number of side chains. 
Effect of NeuZen-NH, on HAI activity of PA(Neu5Ac) 
Using previously established methods [13,25-271, we 
assayed the HAI activities of the set of polymers 
PA(Neu5Ac, x = 0.05,0.2,0.35,0.6, 1 .O) against virally- 
induced agglutination of chicken erythrocytes. The 
HA1 activities were assayed using PA(Neu5Ac) alone or 
using PA(Neu5Ac) in the presence of various concen- 
trations of the NA inhibitor Neu2en-NH2 (Fig. 3a). A 
plot of Ki HA1 (defined as the lowest concentration of an 
inhibitor required to prevent hemagglutination) of 
polymers against X Neu5Ac is shown in Figure 3b. HAI 
activity of the polymer increased rapidly with increas- 
ing x Neu5Ac, reached a maximum at xNru5Ac z 0.4-0.5, 
and then gradually decreased. The molecular basis of 
this variation of activities with changing xNeu5Ac is not 
completely defined, but appears to be a consequence of 
a combination of high affinity, polyvalent binding of 
Neu5Ac groups to HA, steric stabilization of the virus 
by the adsorbed layer of polymer [13,14] and inefficient 
use of Neu5Ac groups at high values of x. 
The dependence of the value of KiHAr of PA(NeuSAc, 
x) on the concentration of Neu2en-NH2 for each value 
of x Neu’Ac (0.05, 0.2, 0.35, 0.6 and 1.0) is plotted in 
Figure 3a.The presence of Neu2en-NH2 in the system, 
at concentrations greater than -0.5 mM, increased 
the effectiveness of PA(Neu5Ac, x) in inhibiting hem- 
agglutination by 2-20 fold (Fig. 3b,c). PA(Neu5Ac, 
x = 1.0) showed the largest enhancement (-20 fold) in 
HA1 activity among tested polymers. There is a sig- 
moidal relationship between the measured value of 
K HA’ and concentrations of the monovalent NA 
inhibitor (Fig. 3a), with the midpoints centered around 
0.07-0.2 mM of the NA inhibitor. 
We suggest two hypotheses to rationalize the synergism 
between polymeric sialosides and monomeric 
inhibitors of NA in inhibiting hemagglutination (Fig. 
4).The synergy might be due to the release of NeuSAc 
moieties on the polymer from active sites of NA (Mode 
a) and/or from binding sites of HA (Mode b) by com- 
petitive binding of Neu2en-NH2. In either case, releas- 
ing Neu5Ac from the surface of the virus would both 
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Fig. 3. HAI activity of PA(Neu5Ac) varies with X, and is 
increased by the addition of the NA inhibitor NeuZen-NHz. (a) 
The values of KiHAr of PA(Neu5Ac, X = 0.05, 0.2, 0.35, 0.6, 1 .O) 
are plotted as a function of the concentration of NeuZen-NH*. 
The arrows indicate the value of the maximum enhance- 
ment (A = K.HAr,NeuZen = ,, / K.HArtNeu2en,) in HAI activity of 
PA(Neu5Ac, ;( = 0.05) by NedZen-NHz. (b) The value of KiHAr 
of PA(Neu5Ac, X) varied with the mole fraction of Neu5Ac 
(XNeuSAc); the detailed shape of the curve depended on the con- 
centration of added Neu2en-NH2 (0 M, dotted line or 1 Om3 M, 
solid line). (c) The maximum enhancements in HAI activities of 
PA(Neu5Ac, X) by NeuZen-NH, are plotted. Hemagglutination 
inhibition assays (at 20 “C) of PA(NeuSAc, X) were performed in 
the presence of various concentrations of NeuZen-NH2 accord- 
ing to standard procedures [24,25] using erythrocytes from 2- 
week-old chicks and influenza A virus (strain X-31). Each 
reported value of Ki HAI is the average of at least five inde- 
pendent trials; the experimental uncertainty in each value is 
approximately f 25 %. 
increase the number of free NeuSAc groups near the 
surface of the virus and decrease the number of contact 
points between the virus and the polymer.We consider 
the influence of these two effects in turn. 
(il Increased concentration of Neu5Ac 
The concentrations of HA and NA used in the assay 
system are estimated to be -2 x lo-lo M and 
-2 x lo-l1 M, respectively, based on the concentrations 
of virus (- 0.06 pg total protein ml-’ corresponding to 
-2 x lo-l3 mole of HA ml-‘).The increase in concentra- 
tion of Neu5Ac by release from binding sites on NA or 
HA is small compared to the total amount of Neu5Ac in 
the system (10-6-10-9 M; Fig. 3); release from NA sites 
could increase the concentration of Neu5Ac groups by 
at most only 1 %. We do not believe that this effect, by 
itself, is sufficient to explain the increase in HA1 activities 
of the polymer in the presence of Neu2en. 
(ii) Decreased number of contacts between the polymer 
and the virus 
Displacing Neu5Ac moieties of the polymer from either 
HA or NA sites would decrease the number of contact 
points between the polymer and the virus. We propose 
that this decrease in the number of attachment points 
will have two effects. First, the average size of the loops 
of polymer formed on the surface may increase. This 
increase is effectively an expansion of the thickness of 
the polymeric gel layer adsorbed to the surface of the 
virus. Such expansion may increase the steric stabiliza- 
tion of the surface of the virus, enhancing the inhibition 
of hemagglutination by the polymer. Second, the affinity 
of the polymer for the viral surface may decrease, which 
may reduce the effectiveness of the polymer. These 
opposing consequences of competitive displacement of 
Neu5Ac from sites on NA or HA may yield different net 
effects depending on the polymer. 
We suggest that displacement of Neu5Ac moieties 
from the NA binding sites (Fig. 4, mode a) is more 
important than displacement from the HA binding sites 
(Fig. 4, mode b) on the basis of two observations. First, 
although Neu2en-NH2 has a high affinity for NA 
(K.NA = 50 nM) [17], it exhibited no HA1 activity even 
at IK.H*I > 50 mM under the same assay conditions. 
Sinci, for monomeric inhibitors, the value of KIHA1 
closely matches the dissociation constant of the 
complex between HA and the inhibitor (KdHA) [9,11], 
this result suggests that the binding of Neu2en-NH2 to 
HA sites (Mode b) is weak (KdHA > 50 mM) and 
therefore is not significant. Second, monomeric 
c-w-0-sialosides, which bind to HA with KIHA1 ^I 
2.5 mM (more tightly than Neu2en-NHJ as well as to 
NA with KdNA -‘I 0.1 mM (much less tightly than 
Neu2en-NHJ, did not affect the HA1 activities of 
polymeric sialosides. 
A non-linear behavior in the factor of maximum 
enhancement of HAI activities (A, which is equal to 
xNeu5Ac (O-0.6).The reason for this behavior is not yet 
completely clear, but may reflect the possible mecha- 
nisms underlying the variation of HA1 activities of 
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Fig. 4. Hypothetical mechanisms, 
describing the possible modes of action 
of PA(Neu5Ac) in inhibition of virally 
induced hemagglutination, and the effect 
of inhibitors of NA on HAI activities of 
PA(Neu5Ac). Polymers inhibit virus by a 
combination of polyvalent binding of 
Neu5Ac moieties to HA sites as well as 
steric stabilization of the surface of virus. 
The latter effect may be caused by 
adsorbed layers of water-swollen poly- 
mers. The presence of NA inhibitor is 
believed to release Neu5Ac from active 
sites of NA (mode a) and/or HA sites 
(mode b), which may subsequently lead 
to expansion of gel layers. 
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PA(Neu5Ac) with xNeu5Ac. Increasing xNeu5Ac of the 
polymer may lead to a positive contribution to HA1 
activities from improved polyvalent binding of the 
polymer to the surface of virus, and to a negative con- 
tribution from a reduced ability of the polymer to sta- 
bilize sterically the viral surface (due to an increased 
persistence length and the greater rigidity of the 
increasingly negatively charged polymer) [ 13,141. A 
linear increase of xNru5Ac of PA(Neu5Ac) led to a 
non-linear decrease in the HA1 activities of the 
polymer in the range of xNeu5Ac > -0.5 (Fig. 3b, 
dotted curve). We hypothesize that, as the value of 
X Neu5Ac increases (especially beyond 0.5), the increase 
in the affinity of the polymer for the surface of the 
virus is marginal, and the decrease in the ability of the 
polymer to stabilize sterically the viral surface is signi- 
ficant. The monomeric inhibitors of NA, according to 
this hypothesis, reduce the negative impact of a 
decreasing ability of the polymers with high values of 
X Ne”5Ac to stabilize sterically the viral surface, while 
marginally reducing the affinities of these polymers for 
the viral surface (Fig. 3b, solid curve). 
[Neu2en],,,a correlates with KdNA for inhibitors of NA 
The concentrations of Neu2en that gave half-maximal 
enhancement of the HA1 activity of all PA(Neu5Ac) 
(referred to as [Neu2en]r,& were -70-200 FM (Fig. 
3a). We hypothesize that the value of [Neu2en]1,2a is the 
concentration of monomeric inhibitor required to dis- 
place a certain fraction of the Neu5Ac groups of the 
polymer bound at the active sites of NA. We assayed 
three inhibitors of influenza NA: Neu2en-NH2 
(KiNA = 50 nM), 
Neu2en-N3 (KiNA 
Neu2en-OH (KiNA = 1 PM) and 
> 1 p,M, [23]). The values of KiHA1 
for PA(Neu5Ac, x = 1.0) at different concentrations of 
Neu2en-NH2, Neu2en-OH or Neu2en-N3 are plotted 
in Figure 5a. The values of [Neu2en]1,28 are 70 P,M, 
300 p,M and 2 2 mM for Neu2en-NH2, Neuaen-OH, 
and Neu2en-N3, respectively. 
How tightly does the polymeric Neu5Ac bind to NA? 
Although the data are limited, there seems to be a cor- 
relation between the values of [Neu2en]1,2A and those 
of KiNA (Fig. 5b). The values of [Neu2en]1,2h for 
Neu2en-NH2 and Neuaen-OH (70 and 300 I.~,M) are 
-800 (?400)-fold higher than the corresponding values 
of K.NA. Furthermore, monomeric sialosides bind 
weakly to influenza NA (KM = 10e4 M) in comparison 
with the inhibitors of NA used here 
(KiNA z KdNA = 1O-6-1O-8 M). These results indi- 
cate that sialosides on the polymer are difficult to dis- 
place from sites on NA even with tight binding 
inhibitors of NA; we interpret the observed discrepancy 
between KiNA and [Neu2en]1,2a as evidence for poly- 
valent, high affinity binding of polymeric Neu5Ac to 
NA sites on the surface of virus. 
In summary, we have demonstrated that HA1 activities of 
polyacrylamides presenting C-sialosides could be 
enhanced by factors of 2-20 by co-application of 
monomeric inhibitors of influenza NA. In addition, our 
results suggest that the potency of a monomeric 
inhibitor of NA in enhancing HA1 activity is inversely 
proportional to the value of KiNA for that inhibitor. 
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Fig. 5. The concentrations of Neu2en that give half-maximal 
enhancement of the HAI activity of PA(Neu5Ac) ([Neu2en],,& 
correlate with the values of Ki NA for the NA inhibitors. (a) The 
values of KiHA1 for PA(Neu5Ac, x = 1 .O) were measured as a func- 
tion of the concentrations of inhibitors of NA (NeuZen-NH,, 0; 
-OH, U; and -N, 0). (b) A plot showing the relationship between 
[Neu2enl,,,, and K NA for these inhibitors of NA. The value of 
KiNA for NeuZen-N3 /s a lower limit; this value has not been deter- 
mined precisely. The uncertainties are approximately + 25 %. 
Significance 
There are a number of approaches, in principle, 
to inhibiting infection by influenza virus. These 
include the induction of anti-influenza antibodies 
and influenza-specific lymphocytes by vaccina- 
tion [28-301, the use of inhibitors of either of the 
two surface proteins of the virus (HA and NA) 
[13-17,25,31-351, and the use of inhibitors that 
block the viral M2 protein (a proton channel) 
[36]. Antibodies act by binding to the surfaces of 
HA or NA [28-301; this action may prevent the 
virus from attaching to cells by competitively 
occupying HA sites, and/or by sterically prevent- 
ing the surface of the target cell from coming 
into close contact with the virus [29]. Due to 
frequent antigenic drift and occasional anti- 
genie shift of viral proteins, the effectiveness of 
antibodies induced from even relatively recent 
strains of the virus is limited in the prevention 
and treatment of influenza [30]. 
Glycopolymers containing Neu5Ac represent a 
class of agents that can block the attachment of 
influenza to its target cell by binding to the 
Neu5Ac binding sites on HA. Polyvalent inhibition 
may be a general strategy to block interaction of 
complementary biological surfaces, which them- 
selves interact polyvalently. This mode of action is 
not used in current antiviral pharmaceuticals, and 
is therefore a potential new entry into this difficult 
area. The practical value of this approach depends 
on issues of toxicity, effectiveness and delivery in 
vivo, and has not been evaluated. 
The unsaturated analogs of Neu5Ac (Neu2en) 
belong to another class of agents that may 
prevent the viral infection by inhibiting the 
action of NA. The present study, which demon- 
strates the synergy of simultaneous application of 
these two classes of inhibitors, widens our under- 
standing regarding the molecular basis of interac- 
tions between polyvalent ligands and clusters of 
receptors on a biological surface. We conclude 
that the observed HA1 activities reflect both 
polyvalent binding of Neu5Ac at HA (and NA) 
sites, and steric stabilization of the virion by 
adsorbed polymer. To our knowledge, this result 
represents the first example of synergy in the 
action of a monovalent inhibitor directed toward 
one receptor and a polyvalent, polymeric 
inhibitor directed toward a second receptor. This 
combination strategy may be applicable to other 
viruses that are structurally and functionally 
similar to influenza virus [37-391. 
Materials and methods 
Materials 
All common chemicals used in this study were purchased 
from chemical suppliers, and were used as received without 
further purification. Polyacrylamides containing clu-C-sialo- 
sides (PA(Neu5Ac, x)) were synthesized according to the 
scheme in Figure 2 by following detailed procedures devel- 
oped in this laboratory [ 131. The monomers Neu2en-NH2 
and Neu2en-N3 were synthesized as described previously 
P213 and Neu2en-OH was purchased from Boehringer 
Mannheim. The synthetic compounds were characterized by 
‘H-NMR and fast atom bombardment mass spectroscopy. 
Phosphate-buffered saline (PBS) used in the HA1 assay was 
prepared by dissolving 80 g NaCl, 2 g KCl, 11 g Na2HP0,, 
and 2 g KH,PO, in 1 1 of deionized H,O, then diluting this 
stock solution lo-fold in deionized H2b, and finally adjust- 
ing the pH of the diluted solution to 7.2 with 1 N NaOH. 
Erythrocytes from two week old chicks were purchased 
from Spafas Inc. An aliquot of erythrocytes (5 ml), supplied 
as a suspension in a storage buffer (5 % by volume), was 
diluted to 50 ml with PBS (pH 7.2), followed by centrifuga- 
tion at 2000 rpm for -7 min at 4 “C. After centrifugation, 
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the supernatant was gently decanted and the pellet was resus- 
pended in PBS (50 ml) followed by further centrifugation; this 
procedure was repeated two more times.At the conclusion of 
the washing steps, the red pellet was resuspended in PBS (50 
ml) and was used immediately in the assay. Influenza virus A 
(strain X-31) was a gift from Professor John J. Skehel at the 
Division ofvirology, National Institute of Medical Research, 
UK. For storage, a stock solution of virus was kept at 4 “C at 
-15 mg of protein per ml. Before use, the suspension was 
diluted by a factor of 5000 with PBS, after which the diluted 
solution was sonicated for -30 s. Monomeric inhibitors of NA 
(Neu’en-NH,, -OH and -N3) were dissolved in PBS at a con- 
centration of 400 mM. The polymers were also dissolved in 
PBS to give a final concentration of Neu5Ac of 0.1-0.01 mM. 
Hemagglutination inhibition assay 
The titer of the prepared PBS solution of X-31 influenza virus 
(-3 pg ml-l) was determined by two-fold serial dilution of 
50 p,l of the virus solution through 12 wells of an 8 x 12-well 
microtiter plate with conically-shaped bottoms [25]. Another 
50 ~1 of PBS was added to each well, followed by a suspension 
of chicken erythrocytes in PBS (100 p.1). The solution was 
mixed and incubated at 20 “C for 1 h.The end point of hem- 
agglutmation is defined as the last well in which a sufficient 
amount of virus remains to agglutinate the erythrocytes. This 
titration was used as the basis of a hemagglutination inhibition 
(HAI) assay [13,25-271. 
HAI assays examining the action of polymer or NA 
inhibitors alone 
A stock solution of polymer (50 p,l of 0.01 n&l) or inhibitor of 
NA (50 p.1 of 400 mM) was two-fold serially diluted through 
12 microtiter wells containing 50 ~1 of PBS. After preparation 
of serially diluted solutions of polymer or NA inhibitor, 50 p,l 
from each well was mixed with 50 ~1 of a suspension of X-31 
virus (0.25 p,g ml-‘). After 30 min of incubation at 20 “C, 
100 ~1 of a suspension of chicken erythrocytes (0.5 ‘%) was 
added to each well followed by gentle agitation and incubation 
for 1 h at 20 ‘C.The end point of HAI is the last well in which 
an agglutinated pellet is observed. This end point (KiHA1) is 
defined as the lowest concentration of inhibitor in solution that 
inhibited the agglutination of erythrocytes by influenza virus. 
The values of KIHA’ were calculated on the basis of four or five 
independent trials. 
HAI assays examining the cooperativity between polymers 
and NA inhibitors 
Each of 192 (96 x 2) microtiter wells (2 plates) was filled with 
50 ~1 of PBS. An NA inhibitor was then serially diluted in 
each column, and the polymer serially diluted in each row, to 
achieve all possible combinations of concentrations. A solution 
(100 ~1) of an inhibitor of NA (typically, 20 mM) was loaded 
in the 12 top wells of one plate (1-12; row A). After thorough 
mixing, an aliquot (100 ~1) from each of the wells in row A 
was transferred to the adjacent well in row B. We continued 
this serial (1.5-fold) dilution over 16 rows. The last aliquot 
(100 ~1) in row P was discarded. After this serial dilution, a 
solution (50 ~1) of a polymer (0.01 mM) was loaded in each 
of the 16 (8 x 2) wells of the two plates under column 1, 
which contained 50 p.1 of the serially diluted solutions of 
monomeric inhibitor. After thorough mixing, an aliquot 
(50 ~1) from each of the 16 wells was taken out, and trans- 
ferred to the adjacent well in column 2.We continued this per- 
pendicular, serial (2-fold) dilution over 12 columns. The last 
aliquot (50 /.~l) was discarded. After preparation of cross-serially 
diluted solutions of polymer and NA inhibitor, 50 ~1 of a sus- 
pension of X-31 virus (0.25 kg ml-‘) and 100 ~1 of chicken 
erythrocytes (0.5 ‘%) were added to the 50 ~1 of solution 
already in each well. The results of this assay were read after 
1 h, and yielded values of K, HA1 for a polymeric inhibitor at 16 
different concentrations of monomeric inhibitor. 
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